| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 06/14/2001 | CA2383001A1 Methods for introducing genes into mammalian subjects |
| 06/13/2001 | EP1105487A1 Recombinant multivalent malarial vaccine against plasmodium falciparum |
| 06/13/2001 | EP1105478A1 Extracellular adhesive proteins, exadh1 and exadh2 |
| 06/13/2001 | EP1105411A1 nrdE |
| 06/13/2001 | EP1105381A1 Dicationic dibenzofuran and dibenzothiophene compounds and methods of use thereof |
| 06/13/2001 | EP1105126A2 Sulfonamides of n-containing heterocyclic thioesters for vision and memory disorders |
| 06/13/2001 | CN1299365A Hygromycin A derivatives |
| 06/13/2001 | CN1298714A Medicine for treating hog cholera |
| 06/12/2001 | US6245745 Bactericides and antiprotozoa agents |
| 06/12/2001 | CA2215982C Nodulisporic acid derivatives |
| 06/07/2001 | WO2001040500A1 Feeding assay for identifying nematicidal compounds |
| 06/07/2001 | WO2001040497A2 Method for obtaining nucleic acids from an environment sample |
| 06/07/2001 | WO2001040248A1 Cryptosporidium sporozoite antigens |
| 06/07/2001 | WO2001040223A2 Aminoheterocyclylamides as pesticides and antiparasitic agents |
| 06/07/2001 | WO2001040216A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 06/07/2001 | WO2001040206A1 Pesticidal n-heteroaryl alpha-alkoximino-carboxamides |
| 06/07/2001 | WO2001040204A1 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient |
| 06/07/2001 | WO2001040195A2 Control of arthropods in animals |
| 06/07/2001 | WO2001039822A1 Device for injection of antiparasitic agents in pets |
| 06/07/2001 | WO2001039803A2 Interleukin-1 muteins useful as vaccine adjuvants |
| 06/07/2001 | WO2001039786A2 New uses of suppressive macrophage activation factors |
| 06/07/2001 | WO2001039778A2 Triazinone compounds for treating diseases resulting from infestation with parasitic protozoans |
| 06/07/2001 | WO2001039720A2 Dna polymerase inhibitors, mikanolide and dihydromikanolide |
| 06/07/2001 | WO2001007612A3 Receptors and associated proteins |
| 06/07/2001 | DE19958388A1 Triazinonverbindungen zur Behandlung von durch den Befall mit parasitischen Protozoen bedingten Krankheiten Triazinone compounds for the treatment of diseases caused by infestation with parasitic protozoa |
| 06/07/2001 | CA2393056A1 New dna polymerase inhibitors, mikanolide and dihydromikanolide |
| 06/07/2001 | CA2393041A1 Method for obtaining nucleic acids from an environment sample, resulting nucleic acids and use in synthesis of novel compounds |
| 06/07/2001 | CA2392933A1 Cryptosporidium sporozoite antigens |
| 06/07/2001 | CA2392931A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 06/07/2001 | CA2392540A1 Feeding assay for identifying nematicidal compounds |
| 06/07/2001 | CA2390415A1 New uses of suppressive macrophage activation factors |
| 06/07/2001 | CA2390113A1 Aminoheterocyclylamides as pesticides and antiparasitic agents |
| 06/07/2001 | CA2388529A1 Pesticidal n-heteroaryl alpha-alkoximino-carboxamides |
| 06/06/2001 | EP1104683A1 Device for the injection of antiparasitic agents into pet animals |
| 06/06/2001 | EP1104465A1 14400 receptor, a g-protein coupled receptor |
| 06/06/2001 | EP1104456A1 Engineered antigen-presenting cells expressing an array of antigens and uses thereof |
| 06/06/2001 | EP1104418A2 Nematicidal pyrazoles |
| 06/06/2001 | EP1104309A2 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods |
| 06/06/2001 | CN1298307A Enhancement of immunity by intranasal inoculation of IL-12 |
| 06/05/2001 | US6242484 Hypoestoxides, derivatives and agonists thereof for use of antiparasitic agents |
| 06/05/2001 | US6242461 Use of aryl substituted azabenzimidazoles in the treatment of HIV and AIDS related diseases |
| 06/05/2001 | US6242457 Oxime derivatives |
| 05/31/2001 | WO2001038393A1 Polypeptides derived from vitamin d nuclear receptor, and their uses in particular for screening vitamin d analogues |
| 05/31/2001 | WO2001038314A1 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors |
| 05/31/2001 | WO2001037837A1 3,4-DIHYDRO-(1H)-QUINAZOLIN-2-ONES AND THEIR USE AS CSBP/p38 KINASE INHIBITORS |
| 05/31/2001 | WO2001037825A1 Injectable preparation for controlling fish live comprising benzoyl urea derivatives |
| 05/31/2001 | WO2001037823A1 Substituted nitrobenzene derivatives as medicines and other useful uses thereof |
| 05/31/2001 | WO2001037819A2 Use of indirubine derivatives for making medicines |
| 05/31/2001 | WO2001037811A1 Composition allowing predefined and controlled release of active ingredient, preparation thereof and use |
| 05/31/2001 | WO2001037808A1 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 05/31/2001 | WO2001037667A1 Combination of n-phenyl-n'-benzoyl urea derivative and nectin compounds for parasite control |
| 05/31/2001 | WO2001009186A3 Therapeutic compounds comprised of anti-fc receptor binding agents |
| 05/31/2001 | WO2000050072A3 Method for the purification, recovery, and sporulation of cysts and oocysts |
| 05/31/2001 | WO2000042071A3 Compounds and methods to inhibit or augment an inflammatory response |
| 05/31/2001 | US20010002398 (6S)- or 10 (6R,S)- tetrahydrofolic acid is crystallized in a polar medium with pH of 3.5 or greater and have a purity 98% |
| 05/31/2001 | US20010002311 Treponema pallidum fused antigen and assay for anti-treponema pallidum antibodies using the same fused antigen |
| 05/31/2001 | CA2706113A1 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 05/31/2001 | CA2390724A1 Combination of fluazuron and invermectin for parasite control |
| 05/31/2001 | CA2389547A1 Injectable preparation for controlling fish live comprising benzoyl urea derivatives |
| 05/31/2001 | CA2387591A1 Use of indirubine derivatives for making medicines |
| 05/30/2001 | EP1103181A1 Combination of N-phenyl-N'-benzoyl urea derivatives and avermectine compounds for parasite control |
| 05/30/2001 | EP1102775A1 Novel phospholipids with unsaturated alkyl and acyl chains |
| 05/30/2001 | EP0886654B1 Thioureido-cyclodextrins particularly useful for solubilising antitumoral and antiparasitic agents, and methods for preparing same |
| 05/30/2001 | CN1297532A Identification of chemical active agents for inhibiting 1-desoxy-D-xylulose-5-phosphate biosynthetic pathway in parasites, and said active agents |
| 05/30/2001 | CN1297352A Use of organophosphoric compounds for therapeutic and preventative treatment of infections |
| 05/29/2001 | US6239160 4-haloalkyl-3-heterocyclylpyridines and 4-haloalkyl-5-heterocyclylpyrimidines, processes for their preparation, compositions comprising them, and their use as pesticides |
| 05/29/2001 | US6239116 Immunostimulatory nucleic acid molecules |
| 05/25/2001 | WO2001036610A1 Human enzymes of the metalloprotease family |
| 05/25/2001 | WO2001036487A2 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/25/2001 | WO2001036452A2 Heteroclitic analogs of class i epitodes |
| 05/25/2001 | WO2001036415A1 Pesticidal aminoheterocyclamide compounds |
| 05/25/2001 | WO2001036408A1 Compounds with antibacterial and antiparasitic properties |
| 05/25/2001 | WO2001035949A2 Treatment or systemic lupus erythematosus (sle) with dehydroepiandrosterone |
| 05/25/2001 | WO2001035739A1 Use of polysiloxanes containing quaternary amino groups as formulation auxiliary agents, and agents containing the same |
| 05/25/2001 | WO2000010582A8 Probiotic, lactic acid-producing bacteria and uses thereof |
| 05/25/2001 | CA2396428A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/25/2001 | CA2392076A1 Human enzymes of the metalloprotease family |
| 05/25/2001 | CA2388705A1 Treatment of sle with dehydroepiandrosterone |
| 05/25/2001 | CA2386341A1 Heteroclitic analogs and related methods |
| 05/25/2001 | CA2386318A1 Pesticidal aminoheterocyclamide compounds |
| 05/23/2001 | EP1101769A2 Nitrogen Containing Erythromycin Derivatives |
| 05/23/2001 | EP1100909A2 Dna replication- and repair-associated proteins |
| 05/23/2001 | EP1100908A2 Human receptor-associated proteins |
| 05/23/2001 | EP1100907A2 Human cytoskeletal proteins |
| 05/23/2001 | EP1100902A1 Keratinocyte derived interferon |
| 05/23/2001 | EP1100813A1 HUMAN BOMBESIN RECEPTOR SUBTYPE-3sb |
| 05/23/2001 | EP1100808A1 Prostate derived ets factor |
| 05/23/2001 | CN1296494A New compound |
| 05/23/2001 | CN1296483A Febrifugine and isofebrifugine and processes for the preparation of both |
| 05/23/2001 | CN1296011A Purine L-nucleoside, its analogue and use thereof |
| 05/22/2001 | US6235756 Methods and compositions for inhibition of angiogenesis by thalidomide |
| 05/22/2001 | US6235283 An isolated polypeptide encoded by a polynucleotide sequence that hybridizes to the complementary strand of an isolated polynucleotide sequence encoding specific amino acid sequence; produces immune response against tick infestationinfestation |
| 05/17/2001 | WO2001034645A2 Mutated il-13 molecules and their uses |
| 05/17/2001 | WO2001034643A1 24 human secreted proteins |
| 05/17/2001 | WO2001034629A1 21 human secreted proteins |
| 05/17/2001 | WO2001034623A1 29 human secreted proteins |
| 05/17/2001 | WO2001034582A2 Sordaricin derivatives having antifungal activity |
| 05/17/2001 | WO2001034566A2 Protease inhibitors |
| 05/17/2001 | WO2001034205A2 Use of lytic toxins and toxin conjugates |
| 05/17/2001 | WO2001034188A1 Malaria vaccine |